INO
INOVIO PHARMACEUTICALS, INC.
Next earnings Aug 10, 2026 · consensus $-0.25 EPS
Last earnings -5.0% on 2026-05-13
$1.10
▼ -2.65%$1.10▼ -43.59%
over 1Y
L $1.05EODHDH $2.87
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.7%
1W-0.9%
1M-12.7%
3M-28.6%
YTD-34.9%
1Y-43.6%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy
Revenue fell -70.0% YoY.
INOVIO PHARMACEUTICALS, INC. shows $65.3K in FY2025 revenue (-70.0% YoY), a -130000.0% net margin, and -352.5% ROE.
Sources: SEC EDGAR (CIK 0001055726, latest 10-Q filed 2026-05-13) · EODHD · as of 6/25/2026, 3:41:03 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.